Integrative pharmacology and systems neuroscience The Integrative Pharmacology and Systems Neuroscience Group (FINS) is the new name adopted by the former Human Pharmacology and Neuroscience Clinical Research Group.
The FINS continues to study pharmacology in a generic way, but with a strong focus on translating research into neuroscience. Our group is linked to the Spanish Research Network on Addictive Disorders (RTA) and the Spanish Biomedical Research Centre Network on the Physiopathology of Obesity and Nutrition (CIBEROBN). The FINS facilities are located within the Barcelona Biomedical Research Park (PRBB). At the PRBB we have more than 200 m2, with an infrastructure of conventional analytical chemistry and molecular biology laboratories as well as an additional 200 m2 dedicated to clinical research for the performance of Phase I and II clinical trials.
The FINS research group, together with the IMIM bioanalysis and analytical services research group and the Proteomics Research Group from the Universitat Pompeu Fabra constitute the BAPP (Bioanalysis, Proteomics and Pharmacology), a member of TECNIO, the group created by ACC1Ó that brings together the main experts in applied research and technology transfer in Catalonia. The BAPP is a reference in the field of chemistry linked to pharmacology, toxicology and the development of new drugs. The BAPP centre develops lines of research that enable: